Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Drugs 83 , 14471453 (2023)
OZEMPICs New Approval Cements Novos Lead in GLP-1 Market The recent approval of OZEMPIC reinforces the growing trend of GLP-1 drugs being used for conditions beyond diabetes and weight loss
The publisher is responsible for the accuracy of the content as published
Pharmacological agents capable of inhibiting the negative regulator(s) of the signalling pathways are expected to potentiate the action of insulin and leptin and therefore be beneficial for the treatment of Type 2 diabetes and obesity
US$ 25.55
US$ 29.24
US$ 20.72
US$ 24.01
US$ 28.08
US$ 28.32
